| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.049 | 0.1 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | -0.078 | 0.1 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.046 | 0.1 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |